Skip to main content
. 2025 Aug 7;25:584. doi: 10.1186/s12872-025-05057-0

Table 2.

Comparison of baseline characteristics in two groups based on whether the IMH existed

Non-IMH
N = 220
IMH
N = 89
Statistical value P value
Age, years, Median (IQR) 57 [47;66] 58 [49;66] Z = −030 0.766
Male, n (%) 190 (86.40) 76 (85.40) X2 = 0.05 0.823
Heart rate, bpm, Mean (SD) 79 [69;86] 80 [73;91] Z = −1.74 0.081
SBP, mmHg, Median (IQR) 129 [121;142] 126 [120;136] Z = −1.26 0.208
DBP, mmHg, Median (IQR) 77 [71;81] 79 [71;83] Z = −1.38 0.169
Hypertension, n (%) 105 (47.70) 45 (50.60) X2 = 0.20 0.652
Smoking history, n (%) 104 (47.30) 38 (42.70) X2 = 0.53 0.465
Killip level, n (%) X2 = 1.78 0.182
I 211 (95.91) 88 (98.88)
II 9 (4.09) 1 (1.12)
Medications
ACEI/ARB, n (%) 164 (74.50) 71 (79.80) X2 = 0.95 0.329
Beta-blocker, n (%) 200 (90.90) 80 (89.90) X2 = 0.08 0.780
PCI procedure
IRA, n (%) X2 = 10.20 0.006
LAD 101 (45.90) 58 (65.20)
LCX 35 (15.90) 12 (13.50)
RCA 84 (38.20) 19 (21.30)
Mutivessel Disease, n (%) 117 (53.20) 52 (58.40) X2 = 0.70 0.402
Stent diameter, mm, Median (IQR) 3.00 [2.75;3.50] 3.00 [2.50;3.50] Z = −1.27 0.203
Stent total length, mm, Median (IQR) 29.00 [21.00;36.00] 29.00 [23.00;35.00] Z =−0.004 0.997
IABP, n (%) 1 (0.45) 2 (2.25) X2 = 5.00 0.200
caIMR>40 U, n (%) 19 (8.64) 51 (57.30) X2 = 85.65 <0.001
LVEF, %, Median (IQR) 49.00 [40.00;55.20] 39.00 [33.00;47.00] Z = −5.52 <0.001
Laboratory data
*Peak cTnT, ng/mL, Median (IQR) 7.67 [6.54;8.42] 8.51 [7.76;8.90] Z = −5.04 <0.001
*CKMB, ng/mL, Median (IQR) 4.48 [3.18;5.47] 5.13 [3.96;5.70] Z = −2.76 0.006
*CRP, mg/L, Median (IQR) 2.48 [1.51;3.32] 2.87 [1.97;3.71] Z = −2.02 0.044
LDL-C, mmol/L, Median (IQR) 2.61 [2.15;3.25] 2.73 [2.14;3.15] Z = −0.37 0.710
SCr, µmol/L, Median (IQR) 70.00 [62.00;79.00] 70.00 [60.00;77.00] Z = −1.03 0.304